890 results on '"Holmgren, Jan"'
Search Results
2. Vaccines Against Diarrhea Caused by Noncholera Bacteria
3. Contributors
4. Cholera Vaccines
5. Evaluating improved inactivated oral cholera vaccines for use in ending endemic cholera by 2030: opportunities and challenges
6. S100A4 exerts robust mucosal adjuvant activity for co-administered antigens in mice
7. Evolution of chain migration in an aerial insectivorous bird, the common swift Apus apus
8. Immune responses against oxidized LDL as possible targets for prevention of atherosclerosis in systemic lupus erythematosus
9. B cells treated with CTB-p210 acquire a regulatory phenotype in vitro and reduce atherosclerosis in apolipoprotein E deficient mice
10. Immunomodulation at Mucosal Surfaces: Prospects for the Development of Antiinfectious and Antiinflammatory Vaccines
11. Mucosal vaccine strategies
12. Cholera Immunity and Development and Use of Oral Cholera Vaccines for Disease Control
13. List of Contributors
14. Alpha-galactosylceramide enhances mucosal immunity to oral whole-cell cholera vaccines
15. Cholera
16. Surface expression of Helicobacter pylori HpaA adhesion antigen on Vibrio cholerae, enhanced by co-expressed enterotoxigenic Escherichia coli fimbrial antigens
17. Human Cultural Evolution Is Completely Immersed in Natural Evolution
18. A parsimonious phylogenetic tree for the swifts, Apodi, compared with DNA-analysis phylogenies
19. A Cholera Toxoid-Insulin Conjugate as an Oral Vaccine against Spontaneous Autoimmune Diabetes
20. Treatment of Experimental Autoimmune Encephalomyelitis by Feeding Myelin Basic Protein Conjugated to Cholera Toxin B Subunit
21. The act of understanding uncertainty is consciousness
22. A novel adjuvanted capsule based strategy for oral vaccination against infectious diarrhoeal pathogens
23. Construction and preclinical evaluation of mmCT, a novel mutant cholera toxin adjuvant that can be efficiently produced in genetically manipulated Vibrio cholerae
24. When, How, and Where can Oral Cholera Vaccines be Used to Interrupt Cholera Outbreaks?
25. Contributors
26. Cholera Vaccines
27. Diarrhea Caused by Bacteria
28. An oral alpha-galactosylceramide adjuvanted Helicobacter pylori vaccine induces protective IL-1R- and IL-17R-dependent Th1 responses
29. Proteomic analysis of cholera toxin adjuvant-stimulated human monocytes identifies Thrombospondin-1 and Integrin-β1 as strongly upregulated molecules involved in adjuvant activity
30. Safety and immunogenicity of ETVAX®, an oral inactivated vaccine against enterotoxigenic Escherichia coli diarrhoea: a double-blinded, randomized, placebo-controlled trial amongst Finnish travellers to Benin, West Africa.
31. Memorial for Nils Lycke
32. Vaccines against enteric infections for the developing world
33. Safety and immunogenicity of an improved oral inactivated multivalent enterotoxigenic Escherichia coli (ETEC) vaccine administered alone and together with dmLT adjuvant in a double-blind, randomized, placebo-controlled Phase I study
34. Chapter 20 - Vaccines Against Diarrhea Caused by Noncholera Bacteria
35. Chapter 15 - Cholera Vaccines
36. Cholera Immunity and Cholera Vaccination
37. Thermostability of the coating, antigen and immunostimulator in an adjuvanted oral capsule vaccine formulation
38. 5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial
39. Adoptive transfer of mucosal T cells or dendritic cells from animals fed with cholera toxin B subunit alloantigen conjugate induces allogeneic T cell tolerance
40. Nasal administration of Schistosoma Mansoni egg antigens-cholera toxin B subunit conjugate to infected mice reduces immunopathology and mortality
41. What a feeling : the underpinnings of physical feelings as molecular level holonomic effects
42. Effect of protein release rates from tablet formulations on the immune response after sublingual immunization
43. Preparation and evaluation of a freeze-dried oral killed cholera vaccine formulation
44. S100A4 exerts robust mucosal adjuvant activity for co-administered antigens in mice
45. Vaccines against Bacterial Enteric Infections
46. Contributors
47. Helicobacter pylori Infection of the Gastric Mucosa
48. Development of Pathogenicity-Driven Definitions of Outcomes for a Field Trial of a Killed Oral Vaccine against Enterotoxigenic Escherichia coli in Egypt Application of an Evidence-Based Method
49. Pathogenesis
50. The Binding of Bacteria Carrying CFAs and Putative CFAs to Rabbit Intestinal Brush Border Membranes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.